Expression of mRNA for the neurotrophin receptor trkC in neuroblastomas with favourable tumour stage and good prognosis

British Journal of Cancer

Volumn 74, Issue 5, 1996, Pages 773-779

  Ryden M ^a   Sehgal, R ^a,e   Dominici, C ^b   Schilling, F H ^c   Ibanez C F ^a   Kogner, P ^d  

^a KAROLINSKA INSTITUTE   (Sweden)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c OLGAHOSPITAL   (Germany)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Childhood cancer; Neurotrophin; Receptor tyrosine kinase; trk

Indexed keywords

MESSENGER RNA; NEUROTROPHIN RECEPTOR; PROTEIN TYROSINE KINASE;

ADOLESCENT; ARTICLE; CANCER STAGING; CHILD; CLINICAL ARTICLE; ENZYME ASSAY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; INFANT; MALE; NEUROBLASTOMA; PRIORITY JOURNAL; PROGNOSIS; RECEPTOR GENE; REMISSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0029764825     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.435     Document Type: Article

References (40)

1. AMBROS IM AND AMBROS PF. (1995). Schwann cells in neuroblastoma. Eur. J. Cancer. 31A, 429 434.
2. BARDE YA, EDGAR D AND THOENEN H. (1982). Purification of a new neurotrophic factor from mammalian brain. EMBO J., 1, 549 553.
3. BJELFMAN C, HEDBORG F, JOHANSSON I. NORDENSKJÖLD M AND PÅLHLMAN S. (1990). Expression of the neuronal form of pp60c-src in neuroblastoma in relation to clinical stage outcome. Cancer Rex., 50, 6908 6914.
4. BORELLO MG, BONGARZONE I AND PIEROTTI MA. (1993). TRK and RET protooncogene expression in human neuroblastoma specimens: high-frequency of trk expression in non-advanced stages. Int. J. Cancer, 54, 540-545.
5. BRODEUR GM, PRITCHARD J, BERTHOLD F, CARLSEN NLT, CASTEL V, CASTLEBERRY RP, DE BERNARDI B, EVANS AE, FAVROT M, HEDBORG F, KANEKO M, KEMSHEAD J, LAMPERT F, LEE REJ, LOOK AT, PEARSON ADJ, PHILIP T, ROALD B, SAWADA T, SEEGER RC, TSUCHIDA Y AND VOÛTE PA. (1993). Revisions of the international criteria for neuroblastoma diagnosis, staging and response to treatment. J Clin. Oncol., 11, 1466 1477.
6. BRODEUR GM, SEEGER RC, SCHWAB M, VARMUS HE AND BISHOP JM. (1984). Amplification of N-myc in untreated human neuroblastoma correlates with advanced disease stage. Science, 224, 1121 1124.
7. BRODEUR GM, SEKHON GS AND GOLDSTEIN MN. (1977). Cytogenctic studies of primary human neuroblastomas. Cancer, 40, 2256 2263.
8. CARON H, MARTINE P, VAN SLUIS P, SPELEMAN F, KRAKER J, LAUREYS G, MICHON J, BRUGIÈRES L, VOÛTE PA, WESTERWELD ARS, DELATTRE O AND VEERSTEG R. (1995). Evidence for two suppressor loci on chromosomal bands 1p35 36 involved in neuroblastoma: one probably imprinted, another associated with N-myc amplification. Hum., Mol. Genet., 4, 535 539.
9. CHAO MV AND HEMPSTEAD BL. (1995). P75 and Trk: a two-receptor system. Trends Neurol. Sci., 18, 321 326.
10. CHIRGWIN J, AEYBLE A, MCDONALD R AND RUTTER W. (1979). Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry, 18, 5294 5299.
11. ERNFORS P. LEE KF, KUCERA J AND JAENISCH R. (1994). Lack of neurotrophin-3 leads to deficiencies in the periferal nervous system and loss of limb proprioceptive afferents. Cell, 77, 503 512.
12. GLASS D, NYE S, HANTZOPOULOS P, MACCHI M, SQUINTO S, GOLDFARB M AND YANCOPOULOS G. (1991). TrkB mediates BDNF NT-3 dependent survival and proliferation of fibroblusts lacking the low affinity NGF receptor. Cell, 66, 405 413.
13. HOEHNER JC, OLSEN L, SANDSTEDT B, KAPLAN DR AND PÅHLMAN S. (1995). Association of neurotrophin receptor expression and differentiation in human neuroblastoma. Am. J. Pathol., 147, 102-113.
14. IBÁǸEZ CF. (1995). Neurotrophic factors: from structure function studies to designing effective therapeutics. Trends in Biotechnol., 13, 217 227.
15. KAPLAN DR, MATSUMOTO K, LUCARELLI F. AND THIELE CJ. (1993). Induction of TrkB by rctinoic acid mediates biologic responsiveness to BDNF and differentiation of human neuroblastoma cells. Neuron, 11, 321-331.
16. KLEIN R, CONWAY D, PARADA LF AND BARBACID M. (1990). The trkB tyrosine protein kinase gene codes for a second neurogenic receptor that lacks the catalytic kinase domain. Cell, 61, 647 656.
17. KLEIN R, NANDURI V, JING S, LAMBELLE F, TAPLEY P, BRYANT S, CORDON-CARDO C, JONES K, REICHARDT L AND BARBACID M. (1991). The trkB tyrosine kinase receptor is a receptor for brain-derived neurotrophic factor and neurotrophin-3. Cell, 66, 395 403.
18. KOGNER P, BJÖRK O AND THEODORSSON E. (1990). Neuropeptide Y as a marker in pediatric neuroblastoma. Pediat. Pathol., 10, 207 216.
19. KOGNER P, BARBANY G, DOMINICI C, CASTELLO MA, RASCHELLA G AND PERSON H. (1993). Coexpression of messenger RNA for trk protooncogene and low affinity nerve growth factor receptor in neuroblastoma with favourable prognosis. Cancer Res., 53, 2044 2050.
20. KOGNER P, BARBANY G, BJÖRK O, CASTELLO MA, DONFANCESCO A, FALKMER UG, HEDBORG F, KOUVIDOU H, PERSON H, RASCHELLA G AND DOMINICI C. (1994). TRK. mRNA and low affinity nerve growth factor receptor mRNA expression and triploid DNA content in favorable neuroblastoma tumors. Prog. Clin. Biol. Res., 385, 137 145.
21. LAMBALLE F, KLEIN R AND BARBACID M. (1991). TrkC, a new member of the trk family of tyrosine protein kinases. is a receptor for neurotrophin-3. Cell, 66, 967 979.
22. LEIBROCK J, LOTTSPEICH AH, HOFER M, HENGERER B, MASIAKOWSKI P, THOENEN H AND BARDE Y-A. (1989). Molecular cloning and expression of brain-derived neurotrophic factor. Nature, 341, 149 152.
23. MARTIN-ZANCA D, OSKAM R, MITRA G, COPELAND T AND BARBACID M. (1991). Molecular and biochemical characterization of the human trk proto-oncogene. Mol. Cell. Biol., 9, 24 33.
24. MARTINSSON T, SJÖBERG RM, HEDBORG F AND KOGNER P. (1995). Deletion of chromosome 1p-loci and microsatellite instability in neuroblastomas analyzed with genetically mapped short-tandem repeat polymorphisms. Cancer Res., 55,(23), 5681 5686.
25. MATSUMOTO K, WADA R, YAMASHIRO JM, KAPLAN DR AND THIELF CJ. (1995). Expression of brain-derived neurotrophic factor and p145 trkB affects survival, differentiation, and invasiveness of human neuroblastoma cells. Cancer Res., 55, 1798 1806.
26. MATSUSHIMA H AND BOGENMANN E. (1993). Expression of trkA cDNA in neuroblastomas mediates differentiation in vitro and in vivo. Mol. Cell. Biol., 13, 7447 7456.
27. MIDDLEMAS DS, LINDBERG RA AND HUNTER T. (1991). TrkB, a neural receptor protein tyrosine kinase: evidence for a full-length form and two truncated receptors. Mol. Cell. Biol., 11, 143-153.
28. NAKAGAWARA A, ARIMA-NAKAGAWARA M, SCAVARDA NJ, AZAR CG, CANTOR AB AND BRODEUR GM. (1993). Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastomas. N. Engl. J. Med., 328, 847 854.
29. NAKAGAWARA A, AZAR CG, SCAVARDA NJ AND BRODEUR GM. (1994). Expression and function of TRK-B and BDNF in human neuroblastomas. Mol. Cell. Biol., 14, 759 767.
30. POLUHA W, POLUHA DK AND ROSS AH. (1995). TrkA neurogenic receptor regulates differentiation of neuroblastoma cells. Oncogene, 10, 185 189.
31. SCHWAB M, ALITALO K, KLEMPNAUER KH, VARMUS HE, BISHOP JM, GILBERT F, BRODEUR G, GOLDSTEIN M AND TRENT J. (1983). Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and neuroblastoma tumor. Nature, 305, 245-248.
32. SEEGER RC, BRODEUR GM, SATHER H, DALTON A, SIEGEL SE, WONG KY AND HAMMOND D. (1985). Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N. Engl. J. Med., 313, 1111 1116.
33. SEGAL R, GOUMNEROVA LC, KWON YK, STILES CD AND POMEROY SL. (1994). Expression of the neurotrophin receptor TrkC is linked to favorable outcome in medulloblastoma. Proc. Natl Acad. Sci. USA, 91, 12867 12871.
34. SHELTON DL, SUTHERLAND J, GRIPP J, CAMERATOT, ARMANINI MP, PHILLIPS HS, CARROLL K, SPENCER S AND LEVINSON AD. (1995). Human trks: molecular cloning, tissue distribution, and expression of extracellular domain immunoadhesins. J. Neurosci., 15, 477 491.
35. SUZUKI T, BOGENMANN E, SHIMADA H, STRAM D AND SEEGER RC. (1993). Lack of high-affinity nerve growth factor receptors in aggressive neuroblastomas. J. Natl Cancer Inst., 85, 377 384.
36. TANAKA T, SLAMON DJ, SHIMADA H, SHIMODA H, FUJISAWA T, IDA N AND SEEGER RC. (1991). A significant association of Haras p21 in neuroblastoma cells with patient prognosis. Cancer, 68, 1296-1302.
37. TRUPP M, RYDÉN M, JÖRNVALL H, TIMMUSK T, FUNAKOSHI H, ARENAS E AND IBÁÑEZ C. (1995). Peripheral expression and biological activities of GDNF. a new neurotrophic factor for avian and mammalian peripheral neurons. J. Cell. Biol., 130, 137-148.
38. TSOULFAS P, SOPPET D, ESCANDON E, TESSAROLLO L, MENDOZA-RAMIREZ JL, ROSENTHAL A, NIKOLICS K AND PARADA LF. (1993). The rat trkC locus encodes multiple neurogenic receptors that exhibit differential response to neutrophin-3 in PC12 cells. Neuron, 10, 975-990.
39. VALENZUELA DM, MAISONPIERRE PC, GLASS DJ, ROJAS ENL, KONG Y, GIES DR, STITT TN, IP NY AND YANCOPOULOS GD (1993). Alternative forms of rat TrkC with different functional capabilities. Neuron, 10, 963-974.
40. WHITE PS, MARIS JM, BELTINGER C, SULMAN E, MARSHALL HN, FUJIMORI M, KAUFMAN BA, BIEGEL JA, ALLEN C, HILLIARD C, VALENTINE MB, LOOK TA, ENOMOTO H, SAKIYAMA S AND BRODEUR GM. (1995). A region of consistent deletion in neuroblastoma maps within human chromosome 1p36.2-363. Proc. Natl Acad. Sci. USA, 92, 5520 5524.